miR26a Modulates Th17/Treg Balance in the EAE Model of Multiple Sclerosis by Targeting IL6

NeuroMolecular Medicine

Volumn 17, Issue 1, 2015, Pages 24-34

  Zhang, Rongwei ^a   Tian, Ayong ^a   Wang, Jun ^a   Shen, Xueli ^a   Qi, Guoxian ^a   Tang, Yanqing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Experimental autoimmune encephalomyelitis; IL6; miR26a; Multiple sclerosis; Th17; Treg

Indexed keywords

INTERLEUKIN 6; MICRORNA 26A; TRANSCRIPTION FACTOR FOXP3; 3' UNTRANSLATED REGION; HYBRID PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN-6, MOUSE; MICRORNA; MIRN26 MICRORNA, MOUSE; MIRN26A MICRORNA, HUMAN; RECOMBINANT DNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; IL6 GENE; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; MOUSE MODEL; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; RNA GENE; TH17 CELL; TRANSLATION REGULATION; UPREGULATION; 3' UNTRANSLATED REGION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

3' UNTRANSLATED REGIONS; ANIMALS; DNA, RECOMBINANT; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTERLEUKIN-6; LENTIVIRUS; MICE; MICE, INBRED C57BL; MICRORNAS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSDUCTION, GENETIC;

EID: 84925532863     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8335-5     Document Type: Article

References (48)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature,431, 350–355.
2. Baecher-Allan, C., & Hafler, D. A. (2004). Suppressor T cells in human diseases. The Journal of Experimental Medicine,200, 273–276.
3. Baltimore, D., Boldin, M. P., O’Connell, R. M., Rao, D. S., & Taganov, K. D. (2008). MicroRNAs: New regulators of immune cell development and function. Nature Immunology,9, 839–845.
4. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature,441, 235–238.
5. Bielekova, B., & Martin, R. (2004). Development of biomarkers in multiple sclerosis. Brain,127, 1463–1478.
6. Chen, X., Howard, O. M., & Oppenheim, J. J. (2007). Pertussis toxin by inducing IL6 promotes the generation of IL17-producing CD4 cells. The Journal of Immunology,178, 6123–6129.
7. Compston, A., & Coles, A. (2008). Multiple sclerosis. Lancet,372, 1502–1517.
8. Cox, M. B., Cairns, M. J., Gandhi, K. S., Carroll, A. P., Moscovis, S., Stewart, G., et al. (2010). ANZgene Multiple Sclerosis Genetics Consortium. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS ONE,5, e12132.
9. Diveu, C., McGeachy, M. J., & Cua, D. J. (2008). Cytokines that regulate autoimmunity. Current Opinion in Immunology,20, 663–668.
10. Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., & Huang, S. (2009). MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nature Immunology,10, 1252–1259.
11. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., et al. (2004). Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. The Journal of Experimental Medicine,200, 277–285.
12. Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., et al. (2005). Reduced suppressive effect of CD4 + CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. European Journal of Immunology,35, 3343–3352.
13. Honardoost, M. A., Kiani-Esfahani, A., Ghaedi, K., Etemadifar, M., & Salehi, M. (2014). miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing–remitting multiple sclerosis. Gene,544, 128–133.
14. Huse, J. T., Brennan, C., Hambardzumyan, D., Wee, B., Pena, J., Rouhanifard, S. H., et al. (2009). The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes & Development,23, 1327–1337.
15. Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., et al. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL17 + T helper cells. Cell,126, 1121–1133.
16. Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., et al. (2009). MicroRNA expression, survival, and response to interferon in liver cancer. New England Journal of Medicine,361, 1437–1447.
17. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001). Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. The Journal of Experimental Medicine,193, 1285–1294.
18. Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., et al. (2009a). MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain,132, 3342–3352.
19. Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., et al. (2009b). MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain,132, 3342–3352.
20. Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., et al. (2009). Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Annals of Neurology,66, 390–402.
21. Keller, A., Leidinger, P., Lange, J., Borries, A., Schroers, H., Scheffler, M., et al. (2009). Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE,4, e7440.
22. Kim, H., Huang, W., Jiang, X., Pennicooke, B., Park, P. J., & Johnson, M. D. (2010). Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proceedings of the National Academy of Sciences,107, 2183–2188.
23. Kota, J., Chivukula, R. R., O’Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H. W., et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell,37, 1005–1017.
24. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., et al. (2005). IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. The Journal of Experimental Medicine,201, 233–240.
25. Lindberg, R. L., Hoffmann, F., Mehling, M., Kuhle, J., & Kappos, L. (2010). Altered expression of miR-17-5p in CD4 + lymphocytes of relapsing-remitting multiple sclerosis patients. European Journal of Immunology,40, 888–898.
26. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., et al. (2002). Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Medicine,8, 500–508.
27. Lorenzi, J. C., Brum, D. G., Zanette, D. L., de Paula Alves Souza, A., Barbuzano, F. G., Dos Santos, A. C., et al. (2012). miR-15a and 16-1 are downregulated in CD4 + T cells of multiple sclerosis relapsing patients. International Journal of Neuroscience,122, 466–471.
28. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature,435, 834–838.
29. Ma, X. T., Zhou, J., Zhong, Y., Jiang, L. I., Mu, P., Li, Y., et al. (2014). Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis. International Journal of Medical Sciences,11, 810–818.
30. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., et al. (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science,317, 256–260.
31. Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011a). Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. The Journal of Immunology,187, 2213–2221.
32. Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011b). Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. The Journal of Immunology,187, 2213–2221.
33. Nelson, P. T., Wang, W. X., & Rajeev, B. W. (2008). MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathology,18, 130–138.
34. Nishihara, M., Ogura, H., Ueda, N., Tsuruoka, M., Kitabayashi, C., Tsuji, F., et al. (2007). IL6–gp130–STAT3 in T cells directs the development of IL17 + Th with a minimum effect on that of Treg in the steady state. International Immunology,19, 695–702.
35. O’Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences,104, 1604–1609.
36. O’Connell, R. M., Rao, D. S., Chaudhuri, A. A., & Baltimore, D. (2010). Physiological and pathological roles for microRNAs in the immune system. Nature Reviews Immunology,10, 111–122.
37. Otaegui, D., Baranzini, S. E., Armañanzas, R., Calvo, B., Muñoz-Culla, M., Khankhanian, P., et al. (2009). Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS ONE,4, e6309.
38. Oukka, M. (2007). Interplay between pathogenic Th17 and regulatory T cells. Annals of the Rheumatic Diseases,66(Suppl. 3), iii87–iii90.
39. Pettinelli, C. B., & McFarlin, D. E. (1981). Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt1 + 2-T lymphocytes. The Journal of Immunology,127, 1420–1423.
40. Sakaguchi, S. (2005). Naturally arising Foxp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self. Nature Immunology,6, 345–352.
41. Sander, S., Bullinger, L., Klapproth, K., Fiedler, K., Kestler, H. A., Barth, T. F., et al. (2008). MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood,112, 4202–4212.
42. Sospedra, M., & Martin, R. (2005). Immunology of multiple sclerosis. Annual Review of Immunology,23, 683–747.
43. Tiscornia, G., Singer, O., & Verma, I. M. (2006). Production and purification of lentiviral vectors. Nature Protocols,1, 241–245.
44. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., et al. (2008). Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. The American Journal of Pathology,172, 146–155.
45. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., et al. (1995). Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. The Journal of Experimental Medicine,182, 1985–1996.
46. Xiao, C., & Rajewsky, K. (2009). MicroRNA control in the immune system: Basic principles. Cell,136, 26–36.
47. Zhang, R., Tian, A., Zhang, H., Zhou, Z., Yu, H., & Chen, L. (2011). Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance. Journal of Molecular Neuroscience,44, 31–40.
48. Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X. R., Tang, Y. J., et al. (2012). The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB 2, TAB 3 and IKK-alpha. Nature Medicine,18, 1077–1086.